SUMMARY
The hexameric ATPase, N-ethylmaleimide-sensitive factor (NSF) is implicated in the release of neurotransmitters and in mediating fusion between intracellular membranes. Due to the conservation of proteins in constitutive and regulated membrane fusion reactions, NSF and its downstream targets have been predicted also to participate in fusion reactions underlying endocrine function, but there is little experimental evidence to support such a role for NSF in insect neuroendocrine secretion. Here we have characterized the NSF orthologue (MsNSF) from the endocrine model for development Manduca sexta. MsNSF is developmentally regulated in endocrine organs of the protocerebral complex. Enrichment of MsNSF in corpora cardiaca (CC) and not in corpora allata (CA) indicates that it might play a preferential role in releasing hormones produced in CC. Endocrine/paracrine cells of the enteric system in M. sexta exhibit selective MsNSF enrichment. Together the data point to a more selective participation of MsNSF in development of M. sexta by its involvement in a subset of factors, whereas other as-yet-unidentified homolog(s) might regulate secretion from CA and a large set of endocrine/paracrine cells. We further characterized the in vivo role of MsNSF by heterologous expression. In contrast to vertebrate NSF, MsNSF is functional in yeast membrane fusion in vivo. MsNSF rectifies defects in SEC18 (yeast NSF homologue) at nearly all discernible steps where Sec18p has been implicated in the biosynthetic route. This underscores the utility of our approach to delineate functional roles for proteins from systems that are not currently amenable to in vitroreconstitution.
Introduction
Membrane fusion events govern key cellular processes. Genetic and biochemical approaches have helped to understand intracellular membrane fusion in general terms by uncovering a large set of factors that is conserved in evolution (Pryer et al., 1992; Rothman, 1994). Among the conserved proteins, the N-ethylmaleimide-sensitive factor (NSF) has received considerable attention due to the central role it plays in most, if not all, membrane fusion reactions (Ikonen et al., 1995; Rothman,1994; Wilson,1995). NSF is recruited to membrane anchors by its cofactor,soluble NSF attachment protein (α-SNAP)(Weidman et al., 1989; Whiteheart et al., 1992). The intrinsic ATPase activity of NSF is stimulated by α-SNAP that is bound to its membrane receptors, SNAREs (Barnard et al., 1997; Morgan et al.,1994). The ATPase activity of NSF is thought to induce conformational changes in SNAREs that disassemble SNARE pairs formed between different intracellular membranes, subsequently leading to membrane fusion(Hanson et al., 1997; Söllner et al., 1993a). NSF-mediated SNARE disassembly has been implicated in many cellular fusion reactions, in both constitutive and regulated processes (for reviews, see May et al., 2001; Rothman, 1994; Whiteheart et al., 2001), but the stage at which such disassembly is required is not entirely clear. NSF is thought to act at a pre-fusion stage(Banerjee et al., 1996),possibly to prime docked vesicles (Golby et al., 2001; Kawasaki et al.,1998; Tolar and Pallanck,1998), or at a postfusion stage to break apart SNARE bundles to recycle components for future rounds of fusion (Littleton et al., 1998, 2001) or in the fusion stage itself as originally proposed (Söllner et al., 1993a,b).
NSF belongs to a superfamily of ATPases that are used in several cellular contexts (Patel and Latterich,1998). Mutations in the yeast NSF homologue, SEC18,affect several steps in yeast biosynthetic and endocytotic pathways(Graham and Emr, 1991; Hicke et al., 1997; Riezman, 1985). Among these fusion reactions, purified Sec18p has been shown to reconstitute endoplasmic reticulum (ER)—Golgi (Barlowe,1997), Golgi—ER (Spang and Schekman, 1998), and vacuole—vacuole fusion(Mayer et al., 1996). Functional conservation of NSF and Sec18p has been demonstrated by the ability of yeast cytosol overexpressing Sec18p to mediate fusion in mammalian in vitro systems employing N-ethylmaleimide (NEM)-treated membranes(Wilson et al., 1989; Woodman et al., 1996). Sec18p is more resistant to NEM than to NSF(Steel et al., 1999) and,given the presence of other NEM-sensitive factor(s) participating in several fusion reactions (Goda and Pfeffer,1991; Rodriguez et al.,1994), these data show only indirectly that Sec18p is a functional homologue of NSF. Thus far, purified Sec18p has been shown to function in a heterologous environment only in permeabilized chromaffin cells(Steel et al., 1999).
Yeast cytosol overexpressing Sec18p could impart transport competence to Chinese hamster ovary (CHO) Golgi membranes in vitro only when its cofactor Sec17p was present. α-SNAP (a cofactor for NSF) does not substitute for Sec17p in these reactions(Clary et al., 1990; Clary and Rothman, 1990; Wilson et al., 1989). Importantly, CHO NSF does not complement yeast SEC18 defects in vivo (Griff et al.,1992), neither is it known to be functional in Sec18p-mediated in vitro reactions. Cdc48p, the yeast homologue of p97 (related to NSF by sequence), participates in ER membrane fusion. Although vertebrate cytosol contains a potent yeast ER fusion activity, purified p97 is inactive in these assays and p97 does not complement CDC48 defects in vivo (Latterich et al.,1995). A simple interpretation for this lack of complementation is that vertebrate NSF and p97 would require their corresponding SNAP(s)(Clary et al., 1990) and p47(Kondo et al., 1997) as cofactors to be functional in yeast.
Information converging from different experimental approaches indicates that homologues of participants in constitutive membrane trafficking might play similar roles in regulated exocytosis of neurotransmitters(Lin and Scheller, 2000) and hormones (Burgoyne and Morgan,1998), but not enough is known about the molecular machinery involved in hormone and neuroendocrine secretion in insect model systems including Drosophila melanogaster. Our interest is in understanding the role and function of homologues of transport proteins in endocrine regulation of the developmental model, Manduca sexta. This system offers several tangible advantages compared to Drosophila; in particular, the neuroendocrine system and factors produced in it have been studied to a greater degree than in any other developmental model(Copenhaver and Truman,1986b).
We have begun an analysis of factors involved in neuroendocrine function of M. sexta, borrowing from the expanding wealth of information in yeast and mammalian cellfree systems. We have previously cloned the M. sexta ortholog of NSF, MsNSF(Pullikuth and Gill, 1999). Here we characterize the in vivo function of MsNSF by using yeast as a tractable model system. Our results show that an animal NSF could genetically replace yeast Sec18p and does not require M. sextaα-SNAP-like protein(s) to be coexpressed to do so. Using an antibody specifically raised against MsNSF, we identified a novel, developmentally regulated role for MsNSF in neuroendocrine cells. Moreover, the selective enrichment of MsNSF in corpora cardiaca (CC) and enteric-endocrine cells of M. sexta suggests that MsNSF plays a preferential role in the secretion of selective hormones, while secretion of others would either be NSF-independent or might prefer as-yet-unidentified NSF homologue(s).
Materials and methods
Plasmids, strains and antibodies
The SEC18 gene (pSEY8-SEC18)(Eakle et al., 1988) was kindly provided by Drs E. C. Gaynor and S. D. Emr, (University of California,San Diego, USA). Wild-type and sec18 strains were obtained from Drs E. C. Gaynor and S. D. Emr, R. Schekman (University of California, Berkeley,USA) and H. Riezman (University of Basel, Switzerland)(Gaynor and Emr, 1997; Hicke et al., 1997; Rothblatt and Schekman, 1989)(Table 1). Antibodies to invertase, carboxypeptidase and α-factor were provided by Drs E. C. Gaynor, S. D. Emr, T. Graham (Vanderbilt University, Nashville, TN, USA), H. Reizman and T. H. Stevens (University of Oregon, Eugene, OR, USA). HSP150 antibody, which works best in immunoblots, was obtained from Dr M. Makarow(University of Helsinki, Helsinki, Finland)(Russo et al., 1992). Antibodies to Sec18p and Sec17p were gifts from Dr W. Wickner (Dartmouth Medical School, NH, USA) (Mayer et al.,1996).
Strain . | Genotype . | Source . |
---|---|---|
X2180-1B | MATα gal2 SUC2 mal mel CUP1 (wild type) | YGSC1 |
RSY 248 | MATα his4-619 (wild type) | R. Schekman2 |
RSY 249 | MATa, his 4-619, ura3-52 (wild type) | R. Schekman |
SEY 5186 | MATα sec 18-1 ura3-52 leu2-3, 112 | E. C. Gaynor and S. D. Emr3 |
ASHY 1896-1 | MATα sec 18-1 ura3-52 leu2-3, 112(pYES2::URA3) | This study |
ASHY 1896-2 | MATα sec 18-1 ura3-52 leu2-3, 112(PGAL-MsNSF::URA3) | This study |
ASHY 1896-5 | MATα sec 18-1 ura3-52 leu2-3, 112(SEC18::URA3) | This study |
ASHY 1896-7 | MATα sec 18-1 ura3-52 leu2-3, 112(PGAL-SEC18::URA3) | This study |
RSY 271 | MATα sec 18-1 ura3-52 his4-619 | R. Schekman |
ASHY 1896-9 | MATα sec 18-1 ura3-52 his4-619 (pYES2::URA3) | This study |
ASHY 1896-10 | MATα sec 18-1 ura3-52 his4-619 (PGAL-MsNSF::URA3) | This study |
RSY 319 | MATα sec 18-2 leu2-3 112 | R. Schekman |
RSY 272 | MATa, his 4-619, ura3-52, sec 18-1 | R. Schekman |
ASHY 18a-11 | MATa, his 4-619, ura3-52, sec 18-1 (pYES2::URA3) | This study |
ASHY 18a-12 | MATa, his 4-619, ura3-52, sec 18-1 (SEC18::URA3) | This study |
ASHY 18a-13 | MATa, his 4-619, ura3-52, sec 18-1(PGAL-SEC18::URA3) | This study |
ASHY 18a-14 | MATa, his 4-619, ura3-52, sec 18-1(PGAL-MsNSF::URA3) | This study |
SEY 5188 | MATα sec 18-1 ura3-52 leu2-3 112 suc 2Δ9 | E. C. Gaynor and S. D. Emr |
ASHY 18-1 | MATα sec 18-1 ura3-52 leu2-3,112 suc 2Δ9(pYES2::URA3) | This study |
ASHY 18-2 | MATα sec 18-1 ura3-52 leu2-3,112 suc 2Δ9(PGAL- MsNSF::URA3) | This study |
ASHY 18-3 | MATα sec 18-1 ura3-52 leu2-3,112 suc 2Δ9(SEC18::URA3) | This study |
ASHY 18-4 | MATα sec 18-1 ura3-52 leu2-3,112 suc 2Δ9(PGAL-SEC18::URA3) | This study |
EGY 1181-5 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 | E. C. Gaynor and S. D. Emr |
ASHY 1181-1 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 (pYES2::URA3) | This study |
ASHY 1181-2 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 (PGAL- MsNSF::URA3) | This study |
ASHY 1181-3 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 (SEC18::URA3) | This study |
ASHY 1181-4 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 (PGAL-SEC18::URA3) | This study |
RH 448 | MATa ura3, leu2, his4, lys2, bar1-1 | H. Riezman4 |
RH 1737 | MATa sec 18-20, ura3, leu2, his4, bar1-1 | H. Riezman |
Strain . | Genotype . | Source . |
---|---|---|
X2180-1B | MATα gal2 SUC2 mal mel CUP1 (wild type) | YGSC1 |
RSY 248 | MATα his4-619 (wild type) | R. Schekman2 |
RSY 249 | MATa, his 4-619, ura3-52 (wild type) | R. Schekman |
SEY 5186 | MATα sec 18-1 ura3-52 leu2-3, 112 | E. C. Gaynor and S. D. Emr3 |
ASHY 1896-1 | MATα sec 18-1 ura3-52 leu2-3, 112(pYES2::URA3) | This study |
ASHY 1896-2 | MATα sec 18-1 ura3-52 leu2-3, 112(PGAL-MsNSF::URA3) | This study |
ASHY 1896-5 | MATα sec 18-1 ura3-52 leu2-3, 112(SEC18::URA3) | This study |
ASHY 1896-7 | MATα sec 18-1 ura3-52 leu2-3, 112(PGAL-SEC18::URA3) | This study |
RSY 271 | MATα sec 18-1 ura3-52 his4-619 | R. Schekman |
ASHY 1896-9 | MATα sec 18-1 ura3-52 his4-619 (pYES2::URA3) | This study |
ASHY 1896-10 | MATα sec 18-1 ura3-52 his4-619 (PGAL-MsNSF::URA3) | This study |
RSY 319 | MATα sec 18-2 leu2-3 112 | R. Schekman |
RSY 272 | MATa, his 4-619, ura3-52, sec 18-1 | R. Schekman |
ASHY 18a-11 | MATa, his 4-619, ura3-52, sec 18-1 (pYES2::URA3) | This study |
ASHY 18a-12 | MATa, his 4-619, ura3-52, sec 18-1 (SEC18::URA3) | This study |
ASHY 18a-13 | MATa, his 4-619, ura3-52, sec 18-1(PGAL-SEC18::URA3) | This study |
ASHY 18a-14 | MATa, his 4-619, ura3-52, sec 18-1(PGAL-MsNSF::URA3) | This study |
SEY 5188 | MATα sec 18-1 ura3-52 leu2-3 112 suc 2Δ9 | E. C. Gaynor and S. D. Emr |
ASHY 18-1 | MATα sec 18-1 ura3-52 leu2-3,112 suc 2Δ9(pYES2::URA3) | This study |
ASHY 18-2 | MATα sec 18-1 ura3-52 leu2-3,112 suc 2Δ9(PGAL- MsNSF::URA3) | This study |
ASHY 18-3 | MATα sec 18-1 ura3-52 leu2-3,112 suc 2Δ9(SEC18::URA3) | This study |
ASHY 18-4 | MATα sec 18-1 ura3-52 leu2-3,112 suc 2Δ9(PGAL-SEC18::URA3) | This study |
EGY 1181-5 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 | E. C. Gaynor and S. D. Emr |
ASHY 1181-1 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 (pYES2::URA3) | This study |
ASHY 1181-2 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 (PGAL- MsNSF::URA3) | This study |
ASHY 1181-3 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 (SEC18::URA3) | This study |
ASHY 1181-4 | MATα sec 18-1 ura3-52 leu2-3,112 his3suc2Δ9 (PGAL-SEC18::URA3) | This study |
RH 448 | MATa ura3, leu2, his4, lys2, bar1-1 | H. Riezman4 |
RH 1737 | MATa sec 18-20, ura3, leu2, his4, bar1-1 | H. Riezman |
Yeast Genetics Stock Center, University of California, Berkeley, USA.
University of California, Berkeley, USA.
University of California, San Diego, USA.
University of Basel, Basel, Switzerland.
Yeast growth conditions
Strains were either grown in rich medium (1 % yeast extract, 2 % peptone)supplemented with 2 % glucose (YPD) or 3 % galactose (YPG) or in minimal synthetic medium [YNB: 0.17 % yeast nitrogen base without amino acids and(NH4)2SO4] supplemented with 0.5 %(NH4)2SO4 and amino acids, depending on the selection required. Cells for metabolic labeling were grown in minimal medium[containing 200 μmol l-1(NH4)2SO4] with selective supplements lacking methionine and uracil, from a saturated culture in rich medium.
Yeast expression construct
The coding sequence from MsNSF cDNA (approx. 5.5 kbp)(Pullikuth and Gill, 1999),was amplified with primers corresponding to the start and stop codon with KpnI and NotI restriction sites, respectively. Upstream(5′-TCCTGGTACCGGTCCATGTCTTCTATGCGTATGAAGGGAGGA-3′) and downstream primers(5′-TTATGCGGCCGCTCATTCTTATTGAATAGTAGTGCCTAGATCTAG-3′)[underlined sequences correspond to coding region of the native open reading frame (ORF)] were used in amplification with Long Template® polymerase chain reaction (PCR) system (Roche Biochemicals). The amplified product was cloned downstream from the GAL1 promoter in the yeast expression vector, pYES2(URA3, Ampr, 2μm ori) (Invitrogen) to yield the plasmid PGAL-MsNSF. This introduced a 55 bp spacer between the GAL1 promoter and the initiator codon of MsNSF. The entire coding sequence of MsNSF in PGAL-MsNSF was sequenced to confirm that no PCR errors were incorporated. A BamHI/HindIII fragment containing the entire reading frame and 5′ untranslated region of the yeast SEC18 (in pSEY8) was cloned into BamHI/HindIII digested pBlueScript (SK+) to yield the construct pASH-SK18. A BamHI/XhoI fragment from pASH-SK18 was cloned into pYES2 to yield the plasmid pASH18GAL, (PGAL-SEC18). Yeast strains were transformed by the lithium acetate method(Ausubel et al., 1994).
Immunoprecipitation of carboxypeptidase Y (CPY) and MsNSF from yeast cells
Cells were grown overnight at 24 °C in YNB with 5 % glucose and supplements, omitting uracil and methionine. Cells equivalent to an A600 of about 50 were pelleted and grown at 24 °C in induction medium (2 % galactose) for 2-8 h as indicated in the figure legends. Prior to labeling, cells were preincubated for the times indicated in the figure legends to impose a complete block of sec18-1. Metabolic labeling was done with trans-35S (ICN Biochemicals) at 25μCi (925 kBq)/1 A600 equivalent of cells. Labeling was stopped by the addition of a chase mixture containing 20 mmoll-1each of methionine, cysteine and (NH4)2SO4. Chase portions (5-10 A600 units) were precipitated with 10% trichloroacetic acid (TCA) on ice. TCA precipitates were pelleted and washed twice with acetone (prechilled at -20 °C) and dried under vacuum. Acetonedried pellets were disrupted with glass beads and immunoprecipitation carried out as previously described(Gaynor and Emr, 1997) using Protein-A sepharose CL4B to sediment the immunocomplexes. After the final wash, the beads were dried under vacuum, resuspended in SDS-PAGE sample buffer and analyzed by SDS-PAGE. Fluorography was performed with Entensify®solutions (DuPont).
Labeling cells for media proteins
About 10 A600 equivalents of cells grown as above were concentrated and resuspended in fresh medium and preincubated for 15 min at 37°C. Bovine serum albumin (500 μg ml-1) andα2-macroglobulin (0.05 units ml-1, Roche Biochemicals) were added prior to preincubation. Cells were labeled and chased as above. The chase was stopped by the addition of NaN3-NaF on ice at a final concentration of 20 mmoll-1 each. The culture medium was separated from cells by centrifugation at 14 000 g for 5 min. Cell pellets and media were precipitated separately with 10 % TCA on ice. TCA precipitates were washed with acetone and dried as described above. Pellets were resuspended by sonication in 50 μl of TETx (10 mmoll-1Tris-HCl, pH 7.5, 1 mmoll-1 EDTA, 0.5 % Triton X-100), an equal volume of SDS-PAGE sample buffer (with 5 % 2-mercaptoethanol) was added, and the samples were heated at 85 °C for 15 min. Denatured samples were clarified at 12 000 g for 5 min and equal A600 equivalents of the supernatants analyzed by SDS-PAGE. Acetone-washed cell pellets were lysed with glass beads and divided into two portions. One portion was immunoprecipitated with α-MsNSF and the other with α-CPY to check for any block of CPY in sec18-1 mutants.
Analysis of HSP150 trafficking
Cells were grown as for labeling medium proteins but in rich medium, YPG (3% galactose). Equal portions were washed twice in water, once in fresh medium and resuspended in prewarmed medium (37 °C) and incubated at 37 °C for 30 min. Cycloheximide was added to a final concentration of 20 μg ml-1 (from a stock of 2 mg ml-1 in 95 % ethanol). Samples were removed just before (0 min chase) or 30 min after the addition of cycloheximide (see Fig. 3Clegend). Cells and media were transferred to 20 mmoll-1NaN3-NaF on ice and separated by centrifugation (14 000 g, 5 min). Cell and media proteins were TCA-precipitated,acetone-washed and air-dried. Precipitates were separated by SDS-PAGE,immunoblotted with anti-HSP150 antibody (1:5000) and detected with anti-rabbit horseradish peroxidase (HRP) antibody (diluted 1:2500) using ECL (Amersham Pharmacia).
Protein extraction, immunoblotting and immunohistochemistry
M. sexta tissue dissection and protein extraction have been described previously (Pullikuth and Gill,1999). Insects were staged and tissues dissected under ice-cold PBS (20 mmoll-1 NaPO4, 250 mmoll-1 NaCl, pH 7.6), then immediately fixed in Bouin's fixative (1:3:0.1, formaldehyde (37%):water-saturated picric acid:glacial acetic acid) or in PBS-buffered 4 %paraformaldehyde at 4 °C overnight. Fixed tissues were processed for whole-mount histochemistry or paraffin sectioning as described(Pullikuth, 1997). Briefly,for wholemounts, the neurilemma was manually removed, rinsed several times in PBST (PBS with 1 % Tween-20) and blocked in PTS (PBST containing 10 % normal goat serum) for at least 5 h at 4 °C. Blocked tissues were incubated with the appropriate antibodies in PTS for 3 days at 4 °C with gentle rocking. Secondary antibodies conjugated to Cy3 (goat antirabbit, for polyclonal primary antibody) or Cy2 (goat antimouse, for monoclonal primary antibodies)(Jackson ImmunoResearch Laboratories, West Groove, PA, USA) were used at a dilution of 1:200 (from a stock diluted 1:2 in 50 % glycerol) in PBST. Fluorescence observations were made with a Zeiss Axiophot fluorescence microscope fitted with the appropriate filters. For thin-section histochemistry, paraffin ribbons (7-10 μm thick) were adhered to poly(lysine)-coated slides treated with gelatin (2 %), deparaffinated in xylene (descending series)/ethanol (ascending series) followed by rehydration to 20 % ethanol. All other steps were the same as above except that antibody incubations were done in a humid chamber overnight and solutions contained 0.1% Tween-20.
Antibodies to insect neuropeptides and hormones
Affinity-purified α-MsNSF antibodies have been described(Pullikuth and Gill, 1999). Antibodies to insect hormones and peptides were generous gifts from the following sources: diuretic hormone and leucokinin (J. Veenstra, University of Bordeaux, France), eclosion hormone, C terminal (Drs T. G. Kingan and M. E. Adams, University of California, Riverside, CA, USA), ecdysis triggering hormone (Drs D. Zitnan and M. E. Adams), proctolin and FMRFamide (T. G. Kingan), bombyxin (D. Zitnan), M. sexta prothoracicotropic hormone,PTTH (Dr W. Bollenbacher, University of North Carolina, NC, USA), small cardioactive peptide B, SCPB (Dr D. Willows, University of Washington, WA, USA), silkmoth period and PTTH (Drs I. Sauman, S. Reppert and T. Gotter) and Drosophila synaptotagmin (Dr Hugo Bellen, Baylor College of Medicine, Texas, USA). Monoclonal antibody (HPC-1) to syntaxin was purchased from Sigma (St Louis, MO, USA).
Results
Expression constructs
The consensus sequence surrounding the initiation codon in yeast,A/pyAA/UAUGUCU, differs from that in the vertebrate CA/GCCAUGG (Romanos et al.,1992). The native MsNSF cDNA contains an excellent consensus around the initiation codon (AAAAATGTCTTCT)for expression in yeast. Our in vitro manipulation introduced a T residue at -3 (with respect to ATG) and retained the critical TCT TCT (second and third codon) and TAA (stop) without altering any other sequence in the ORF. In vitro translation of this construct yielded a doublet of 81 and 83 kDa similar to the native 5.5 kbp clone in pSPORT(Pullikuth and Gill, 1999) and to in vitro and in vivo translated Sec18p(Eakle et al., 1988). Introduction of this expression construct PGAL-MsNSF into yeast produced immunoprecipitable protein when induced with galactose (see below). Additional MsNSF constructs were made by cloning the 540 bp 5′ region upstream from the SEC18 initiator codon to MsNSF ORF in pYES2(PGAL-5′-SEC18-MsNSF) and pSEY8. These constructs did not yield significant MsNSF expression in yeast and, in the case of former,expression was detected only when induced with galactose (not shown). Thus the PGAL-MsNSF construct was used in the experiments described here. Initial experiments were done with both sec18-1(Novick et al., 1980) and sec18-20 (Hicke et al.,1997) alleles (Table 1). Under restrictive conditions growth phenotype and transport of CPY were similar in both strains with different genetic backgrounds, thus MsNSF in the sec18-1 allele was characterized further.
Rescue of sec18-1 temperature-sensitive growth defect by heterologous expression of MsNSF
Drosophila has two NSF homologues(Boulianne and Trimble, 1995; Ordway et al., 1994; Pallanck et al., 1995b);however, neither is known to be involved in intra-Golgi transport in vitro or in vivo, much less to be functional in yeast. The mutant allele sec18-1 exhibits temperature-sensitive growth inhibition at ≥28 °C, whereas its growth is similar to wild type at 24°C (Fig. 1A). To test if MsNSF possesses Sec18p-like activity, MsNSF was expressed under the regulation of the GAL1 promoter, which could be induced to high levels with galactose(Table 2). Sec18-1 cells containing PGAL-MsNSF or SEC18 gene with its native 5′ region, or PGAL-SEC18, were spotted on galactose-containing medium and grown at permissive and non-permissive temperatures (Fig. 1A,B). The temperature-sensitive growth was rescued by MsNSF expression in sec18-1 cells, which was comparable to wild-type or SEC18-carrying cells at 30 °C(Fig. 1A). Without prior induction of MsNSF, complementation was only modest at 37 °C(Fig. 1A).
Plasmid . | Carbon source (%) . | Induction time (h) . | Expression level* . |
---|---|---|---|
pSEY8-SEC18 | Glucose (5) | 18 | 31±2 |
Raffinose (2) | 16 | 27±4 | |
Galactose (2) | 4 | 29±6 | |
16 | 30±8 | ||
PGAL-SEC18 | Raffinose (2) | 16 | 30±2 |
Galactose (2) | 4 | 100±11 | |
16.5 | >375 | ||
PGAL-MsNSF | Glucose (5) | 18 | ND |
Raffinose (2) | 16 | ND | |
Galactose (2) | 4 | 65±17 | |
16.5 | >225 |
Plasmid . | Carbon source (%) . | Induction time (h) . | Expression level* . |
---|---|---|---|
pSEY8-SEC18 | Glucose (5) | 18 | 31±2 |
Raffinose (2) | 16 | 27±4 | |
Galactose (2) | 4 | 29±6 | |
16 | 30±8 | ||
PGAL-SEC18 | Raffinose (2) | 16 | 30±2 |
Galactose (2) | 4 | 100±11 | |
16.5 | >375 | ||
PGAL-MsNSF | Glucose (5) | 18 | ND |
Raffinose (2) | 16 | ND | |
Galactose (2) | 4 | 65±17 | |
16.5 | >225 |
Representative of three experiments.
ND, below the detection limit of antibody.
Glucose suppresses GAL1 promoter activity. Raffinose neither suppresses nor induces GAL1 promoter, suggesting that the GAL1 promoter is constitutively active when raffinose alone is provided as carbon source. Cells were grown as above and spotted on medium containing different carbon sources. As shown in Fig. 1B, sec18-1 failed to grow at 32 °C, but this was alleviated by MsNSF expression when induced with galactose. This rescue was completely suppressed by glucose and raffinose, which indicates that the growth phenotype was a direct effect of MsNSF expression. Under constitutive levels of expression with raffinose,MsNSF failed to rescue the temperature-sensitive phenotype(Fig. 1B), strongly suggesting that the rescue was dose-dependent. It is noteworthy that PGAL-SEC18 could not be completely suppressed by glucose or raffinose, suggesting that it is constitutively expressed due to the presence of 5′-region of SEC18 in the construct. Constitutive levels of Sec18p are thus sufficient to rescue temperature-sensitive growth in sec18-1 mutants.
Several of the sec mutants accumulate intra-cellular structures and lyse after prolonged exposure to non-permissive temperatures(Novick et al., 1980; Riezman, 1985). Cells were incubated at 37 °C for 8 days, returned to 22 °C and incubated for 4 days. MsNSF-containing cells remained viable and were capable of growth after this prolonged exposure to restrictive temperature, while sec18-1 cells as expected were unable to revive growth(Fig. 1C). These data clearly demonstrate that an animal NSF is capable of rescuing the temperature-sensitive phenotype when expressed in sec18 mutant, and does not require the activity of animal SNAPs to do so.
To obtain biochemical support for the above data, cells grown at various induction conditions were analyzed by immunoblotting lysates withα-MsNSF and α-Sec18p antibodies(Table 2). Induction time and carbon source affected the level of expression of MsNSF. Twice as much MsNSF was expressed after induction for 4 h in galactose, compared to Sec18p expressed from its native 5′ region; this level only marginally rescued the temperature-sensitive defect at 37 °C. However, rescue was complete up to 32 °C (Fig. 1). MsNSF levels needed to be eight- to ninefold higher than native Sec18p for complete complementation. Due to large variations between experiments it was not possible to conclusively identify the minimal level of MsNSF required for rescue, and the levels reported here might be overestimated.
Rescue of transport defect by expression of MsNSF
In yeast, SEC18 is an early acting gene, and defects in it cause secretory proteins to arrest in the ER-modified forms when shifted to restrictive temperatures. Additional defects in sec18-1 mutant were detected in intra-Golgi and Golgi-plasma membrane routes of transport(Graham and Emr, 1991). The data shown above clearly indicate the feasibility of using yeast as a model system to understand the in vivo role(s) of proteins from heterologous systems where assays to understand such roles are not available. To analyze the role of MsNSF in intracellular protein transport, we chose three well-characterized markers, carboxypeptidase Y (CPY), alpha factor(α-F) pheromone and heat shock protein 150 (HSP150).
MsNSF restores CPY transport to the vacuole in the sec18-1 mutant
CPY is a 61-kDa subunit enzyme of which 10kDa is contributed by four N-linked oligosaccharide modifications. In wild-type cells, CPY targeted to the ER is modified by the addition of core oligosaccharides (p1 form, 67kDa), and is further modified in the Golgi (p2 form, 69kDa). The p2 form is sorted to the vacuole where it is proteolytically processed to yield the mature form of the enzyme (mCPY, 61 kDa)(Hasilik and Tanner, 1978; Stevens et al., 1982). Mutations in SEC18 affect the transit of CPY to the distal Golgi compartment (Graham and Emr,1991). If MsNSF could replace the defective Sec18p in vivo then the ER-arrested form (p1) should be matured to mCPY under restrictive conditions. Fig. 2shows the comparative maturation of CPY in sec18-1, MsNSF and SEC18 cells. After induction for 2h, when cells were labeled after incubation at 33°C for 30 min, sec18-1 cells accumulated p1 CPY,which failed to mature during the chase period(Fig. 2A, lanes 1-3). This transport block was rescued by the expression of MsNSF, which yielded the mature vacuolar form, mCPY (lanes 10-12). MsNSF mediated rapid vacuolar transport since 42% mCPY was recovered at 0 min of chase (lane 10). The above data was quantitated from three experiments by densitometry of digitized images. In MsNSF-, SEC18- and Pgal-SEC18-expressing cells, mCPY maturation, after a 30 min chase, was approx. 78 %>95 % and 84%, respectively(Fig. 2A). Since expression levels under longer induction showed phenotypic rescue, cells were induced for 6 h before temperature shifts and analyzed for CPY maturation(Fig. 2B,C). Consistent with the phenotypic data (Table 2, Fig. 1), higher levels of MsNSF expression facilitated mCPY formation, but was kinetically slower than wild type (Fig. 2, compare lane at 30 min in B with corresponding lane in C). From these results we conclude that MsNSF expression could substitute for a mutant Sec18p in vivo in mediating intracellular trafficking of CPY. Functional substitution by MsNSF does not require any other fusion-promoting factors such as Sec17p or Rab homologues from M. sexta to exert its action in yeast. This is the first demonstration of an in vivo expression-dependent function for an animal NSF in intra-Golgi transport.
Intra-Golgi transport of yeast pro-alpha-factor is restored by MsNSF in sec18 mutants
In sec18 cells, the mating pheromone α-F is predominantly in the ER-modified form under non-permissive conditions. Transfer to the Golgi results in the addition of complex sugars in a compartment-specific manner,producing the hyperglycosylated form. In a distal Kex2p-containing compartment the prohormone is processed to the mature 13-amino-acid-residue active pheromone that is secreted into the medium. The addition of different sugars at distinct levels of Golgi organisation results in distinguishable forms of the prohormone that can be resolved by their migration on SDS—PAGE. The nature of sugar modification indicates the level of Golgi organisation that the protein has reached. In sec18-1 cells at 33 °C, only the core glycosylated ER form predominated, which failed to mature into the Golgi forms during the 30 min chase period at non-permissive temperature(Fig. 3A, lanes 1,2). The complete lack of α-1,6 and α-1,3 modified Golgi forms in the immunoprecipitates strongly suggested that, under our conditions, the core glycosylated prohormone was never delivered to the Golgi. In contrast, in MsNSF-expressing cells, even at 0 min chase, the predominant forms were Golgi-modified, corresponding to the sizes of both α-1,6 and α-1,3 mannose added forms (G; Fig. 3A, lane 5). These results suggested that the functionality imparted by active MsNSF is sufficient to provide rapid transport ofα-factor through the compartment. After a chase for 30 min, cells were shifted to permissive temperature (24°C) to allow for resumption of transport of ER-locked forms (lanes 3,4 and 7,8) and to demonstrate thatα-factor in sec18-1 cells can acquire Golgi-specific modifications as expected for permissive conditions. It should be noted that MsNSF expression resulted in a rapid disappearance of Golgi-modified form,presumably by secreting the mature protein into the medium(Fig. 3A, lane 7; see legend). Together the data (Figs 2, 3A) suggest that MsNSF alleviates a Sec18p defect in vivo for two well-characterized secretory markers in intra-Golgi transport.
Golgi to plasma membrane and exocytosis
Consistent with the NSF interaction with neuronal SNAREs(Söllner et al., 1993b),Graham and Emr (1991) showed that Sec18p acts in the exocytotic pathway from post-Golgi to plasma membrane. However, purified Sec18p has not been shown to be required for this step. We used a secretion assay (Gaynor and Emr,1997) to determine if MsNSF could functionally restore the late stage in exocytosis. This assay does not place bias on any particular protein but qualitatively assesses whether proteins in a size range are secreted into the medium after imposing a temperature block prior and during pulse-chase protocols. Cells were grown in induction medium and subjected to restrictive conditions for 30 min at 37°C (Fig. 3B). After being subjected to a pulse-chase protocol, equal portions of labeled cultures were separated into medium and cell fractions,and analyzed by SDS-PAGE and fluorography.
Medium proteins were absent from sec18-1 mutants(Fig. 3B, lane 2). At least seven protein bands (arrows, Fig. 3B) were apparent in sec18-1 complemented with MsNSF(Fig. 3B, lane 4), similar to SEC18-carrying cells (Fig. 3B, lane 3). Among the predominant proteins whose secretion was blocked by SEC18 mutation, the protein of approx. 150kDa(Fig. 3B, lanes 1,3,4)corresponds to the well-characterized heat shock protein HSP150(Russo et al., 1992).
HSP150 is induced approximately sevenfold under heat stress and is extensively O-glycosylated (Russo et al., 1992). Functional Sec18p is required for the secretion of HSP150 since in sec18-1 it is predominantly found in the ER form under restrictive conditions (Gaynor and Emr, 1997). Cells were incubated at 37°C for 30 min, washed in prewarmed (37°C) medium and incubated for 30 min with cycloheximide(Fig. 3C). Portions were removed prior to addition of cycloheximide (0 min chase, odd-numbered lanes). Cells were collected at 37°C, washed in prewarmed medium twice, and incubation continued for 30 min with cycloheximide(Fig. 3C, even-numbered lanes). Medium proteins were separated by electrophoresis and analyzed by immunoblotting with HSP150 antibody. As expected in wild type (WT), HSP150 was efficiently secreted into the medium (Fig. 3C, lanes 1,2), whereas no detectable HSP150 was found in the medium from sec18-1 cells (Fig. 3C, lanes 3,4). Expression of MsNSF or SEC18 rescued this block of HSP150 (Fig. 3C, lanes 5-10). Sec18p has not been localized to fusion complexes formed during exocytosis, i.e. the exocyst complex, nor has purified Sec18p been shown to reconstitute this step in vitro. However, in sec18-1 mutants, components of this complex are localized to discrete sites in the plasma membrane, indicating a potential role for Sec18p in mediating exocytosis from the exocyst complex formed at the plasma membrane(Carr et al., 1999). The fact that MsNSF could relieve this late Golgi transport step suggests that MsNSF is indeed functional in post-Golgi trafficking, and could replace a mutant Sec18p defect precisely at that point of the exocytotic pathway.
Stage-, tissue- and cell-type-specific expression of M. sexta NSF
The level and pattern of MsNSF protein expression were analyzed with antibodies against the D1 domain of MsNSF. These preparations specifically recognized a 83kDa protein in immunoblots, consistent with the estimated size of MsNSF. MsNSF expression was highest in the central nervous system and the brain of larval and pupal stages of M. sexta(Fig. 4A), extending our previous observation (Pullikuth and Gill,1999). Preimmune sera, or sera depleted by preincubating with the D1 domain of MsNSF, completely abolished the signal in immunoblots (not shown). Affinity-purified antibodies specifically immunoprecipitated in-vitro-labeled MsNSF (Pullikuth and Gill, 1999) and metabolically labeled MsNSF from cells carrying the MsNSF expression vector, but not from isogenic cells expressing Sec18p from a multicopy vector (pSEY8) or from an inducible expression vector(Pgal) (Figs 2, 3B).
M. sexta is an excellent model to study neuroendocrine determinants in animal development as it has already been used as a system to identify and isolate several hormones and peptides involved in metamorphosis. The ontogeny and physiological roles of neuroendocrine cells in this system have been resolved to a far greater extent than in any other insect species(Copenhaver and Truman, 1986a,b). Although two isoforms of NSFs (dNSF1 and 2) have been isolated in Drosophila, their expression pattern at the protein level is not well understood. dNSF1 mRNA is expressed at higher levels in head and embryonic CNS(Ordway et al., 1994), whereas dNSF2 is ubiquitously expressed, suggesting a more generalized role in constitutive protein trafficking (Boulianne and Trimble, 1995; Golby et al., 2001; Pallanck et al.,1995b). Thus far, NSF protein has not been localized in endocrine organs in the brain. We focused on three aspects for further characterization. First, the enteric nervous system (ENS) was used as a model to understand the non-neuronal distribution. Second, we analyzed the anterior protocerebral neurosecretory complex during all developmental stages. Finally, we characterized a novel NSF reactivity in a specific set of neurosecretory cells that are regulated in development.
MsNSF in enteric nervous system (ENS)
M. sexta ENS consists of 80-100 neurons clustered in the enteric plexus in the anterior midgut (Fig. 4B). These neurons send axonal projections along the entire length of the organ (B) and innervate the proctodeal nervous system, terminating in varicosities indicative of hormone release sites(Truman, 1992). Apart from the ENS neurons, which modulate muscle activities of midgut, a slew of endocrine/paracrine cells (EPC) lines the entire length of midgut. These cells are peptidergic in nature and contain molecules antigenically similar to vertebrate neuropeptides and hormone. Further, the midgut is a rich source of ecdysteroids, which dictate the fate of the developing insect by rising and falling titers. ENS neurons and EPC could be marked by FMRFamide reactivities that stain a variety of peptides with FMRF epitopes(Fig. 4B,C)(Zitnan et al., 1993). Whole-mount immunohistochemistry was performed on isolated midguts from neonate larvae. Two distinct patterns of NSF reactivities were evident. A diffused staining pattern, apparent only with α-MsNSF antibodies, which we term as Type I NSF immunoreactivity (NSF-IR), was evident. This signal was specific since negative control experiments done in parallel produced little staining (not shown). Type I NSF-IR reflects the presence of MsNSF in most cells, consistent with its constitutive role(s). On the other hand, a pattern of enriched NSF-IR, which we term eNSF-IR, was restricted to perhaps six rows in the median midgut (Fig. 4D). FMRFamide reactivities were present in approximately 12 rows of EPC along the entire length of midgut (Fig. 4C). eNSF-IR was excluded from ENS neurons and axons, and from EPC of anterior and posterior midgut.
EPCs consist of two predominant types of cells, closed and open. Larval midgut consisted of one (Fig. 4F) or two (Fig. 4F, inset) eNSF-IR cells per invagination exclusively restricted to the closed cell type. We call them pediculate EPCs, since stalked processes project into the lumen of the midgut. No eNSF-IR was found in open EPCs. The eNSF-IR EPC cell body is exposed to hemolymph and thus strategically poised to relay hormonal information from the hemolymph to the midgut lumen. The spectra and identity of hormones produced in each type of EPC are not known, although many react to antibodies against vertebrate neuropeptides and hormones, and are thus thought to contain antigenically similar factors.
The midgut is composed primarily of two cell types, columnar cells and secretory goblet cells. An intermediate staining pattern, termed Type III,with a median midgut bias was found mostly restricted to the basolateral domain of goblet cells (Fig. 4E). Columnar cell staining was unremarkable. The localization pattern of MsNSF in the basolateral domain is consistent with studies performed in vitro where vertebrate NSF was shown to be required for transport from the TGN to the basolateral membrane. Diminished or lack of staining in most other cells points to the possibility that NSF-independent mechanisms, or other unidentified NSF isoforms, might be involved in trafficking in a majority of midgut cells. Exclusion of NSF-IR in enteric neurons and axons bolsters the claim that multiple MsNSF isoforms or functionally similar molecules would govern release processes in this important group of neurons, modulating various aspects of feeding, digestion and ecdysis. The selective expression of NSF is likely to exist in other species, as Drosophila midgut and gastric ceacae exhibited regional and cell-type-specific NSF enrichments with the same antibodies (A. K. P., M. Filippova and S. S. G., unpublished observations). In the Malpighian tubules,most NSF-IR was found restricted to the plasma membrane(Fig. 4G,I).
NSF reactivity in optic and antennal lobes of M. sexta
In the optic lobe most photoreceptors exhibited NSF-IR, largely restricted to cytoplasmic regions (Fig. 4M). Three granular structures of the optic lobe, namely lobula,medulla and lamina, stained for MsNSF (Fig. 4K,L), indicating a role for MsNSF in visual perception and integration of sensory information in M. sexta. No specific groups of cells of the optic lobe showed eNSF-IR. Distinct groups of cells containing neuropeptides and neurotransmitters have been localized in the optic lobe;however, the lack of specific enrichment in any of these cells suggests that MsNSF is expressed to similar extent in most types of peptidergic and neurotransmitter-containing cells of the optic lobe. In the antennal lobe,glomeruli (g) stain for MsNSF (Fig. 4H) where sensory inputs are integrated. Afferent nerves from glomeruli innervate the mushroom body, a critical structure implicated in learning and memory in insects.
NSF-IR in the neurosecretory complexes of M. sexta brain
Components of NSF-mediated complex have been predicted to regulate exocytotic events, including hormonal secretion. However, to date, there is no direct evidence for the presence of NSF in insect neurosecretory cells or sites of hormone release. The protocerebral neurosecretory complex of M. sexta consists of several paired cells with distinct content catalogue and defined axonal ramifications (Copenhaver and Truman, 1986a,b; Zitnan et al., 1995a). Whole-mount immunohistochemistry was performed on brains from staged and sexed animals. The expression pattern of MsNSF was unremarkable in larval brain. Surprisingly, beginning with day 3 after pupal ecdysis, four cells in the anterior protocerebrum showed eNSF-IR (Fig. 5C) apart from the specific diffused Type I-IR found in all regions (Fig. 5B). eNSF-IR in these two pairs was sustained throughout later development and persisted after adult emergence (Fig. 5C-E). eNSF-IR in these cells was not sexually dimorphic (not shown), thus was unlikely to be involved in sex-specific traits. To rule out the possibility that the size of tissues in whole mounts might mask other reactivities,paraffin sections of pharate adult were examined with the same antibody. Confirming our results, only four cells expressed the eNSF-IR phenotype(Fig. 5G, arrow; only one from each pair in the plane of section shown). eNSF-IR was not due to problems of antibody penetration since α-FMRFamide stained several groups of cells and axons at all levels (Fig. 5F). Synaptotagmin and syntaxin antibodies stained all cells in the protocerebral complex equally, suggesting that these important components in membrane fusion are not preferentially expressed in these cells (data not shown).
Axonal processes from these eNSF-IR cells were weakly detected after 7 days of pupal ecdysis, gradually increasing in staining intensity toward adult development (Fig. 6F). Brain eNSF-IR is curiously poised within a cluster of cells constituting the major neurosecretory atrium in protocerebrum. Hormones involved in homeostasis,cellular differentiation, egg development, vitellogenesis and eclosion have all been localized to specific sets of cells within this complex. Peptides and hormones produced from this complex are released from either of the two major neurohemal organs, corpora cardiaca (CC) and corpora allata (CA), both posterior glandular structures connected to the brain through nervi corpora cardiaca (NCC). Despite both CC and CA being principal sites of peptide/hormone release, each is involved in releasing a subset of hormones during development. Given the putative role of NSF in mediating neurotransmitter release, we examined MsNSF expression in peptide/hormone release structures in M. sexta. CC—CA complexes from ecdysing pupa to adult insects were analyzed by whole-mount immunohistochemistry with affinity-purified α-MsNSF. Remarkably, only CC was found to produce eNSF-IR with distinct varicosities characteristic of hormone release sites(Fig. 5H,I). However, this pattern of eNSF-IR in CC was also present in larval stages (data not shown),albeit less intense. The preferential enrichment of NSF in one of the two major sites for hormone/peptide release suggests that it is involved in regulating the release of only a subset of factors produced in the brain. No change in eNSF-IR in CC was detected between larval—larval,larval—pupal, and pupal—adult ecdyses, ruling out the possibility that MsNSF is directly associated with ecdysis and eclosion.
To understand if eNSF-IR in M. sexta brain colocalized with distinct neuropeptides, immunostaining was performed with antibodies against eclosion hormone (EH) (Copenhaver and Truman, 1986a), PTTH(Westbrook et al., 1993),diuretic hormone (DH), leukokinin(Veenstra and Hagedorn, 1991),period (Sauman et al., 1996)and bombyxin (Zitnan et al., 1990, 1995b). Bombyxin, an insulin-related molecule that primes the prothoracic glands to secrete the ecdysis hormone, ecdysteroid, is produced in four pairs of cells. Since the location of bombyxin cells was similar to eNSF-IR cells, double immunostaining with α-MsNSF and α-bombyxin was performed. Signals were detected with anti-mouse-cy2 conjugated secondary antibody to visualize bombyxin reactivity (Fig. 6A, green),while anti-rabbit-cy3 conjugated antibody detected MsNSF-staining cells(Fig. 6A, red). These eNSF-IR cells did not coincide with any of the bombyxin-reactive cells as apparent from the lack of colocalization. Another candidate set of cells is those producing DH, which localize to the dorsal protocerebrum in larval stages. During pupal—adult development, DH production is shut off in these cells and production is shifted to a cluster of 8-10 smaller cells in early pupa and 80-100 cells in late pupa/adult (Fig. 6B), all probably arising from a common neuroblast in later stages(Veenstra and Hagedorn, 1991). The presence of these cells in later stages is controversial, since DH reactivity is the only known criterion for their identification. During adult metamorphosis these cells are thought to be lost or atrophied. However,α-MsNSF antibodies detect two pairs lateral to the cluster of 80-100 cells staining for DH (Fig. 6C). The sheer size difference and localization rules out any subset of DH cells to express eNSF-IR. However, it should be noted that these are the same cells that express DH in larva.
Eclosion hormone (EH) is one of the major determinants of ecdysis in M. sexta and directs its action through a cascade of hormonal signaling. EH in larva is produced by two pairs of ventro-medial (VM) cells(Fig. 6D). VM cells undergo migration concomitant with the gross rearrangement of the brain during pupal and adult development. Fusion of subesophageal ganglion with the brain coincides with VM cells being ventrally positioned in the anterior protocerebrum of late pupa/adult brain(Fig. 6E). EH in late stages is thought to be released primarily from CC-CA complex, as distinct from the proctodeal system in larva. To rule out the possibility that eNSF-IR cells were EH cells, cells stained for α-EH(Fig. 6E) and eNSF-IR(Fig. 6F) were examined both from dorsal and ventral aspects. Axons from eNSF-IR cells project ventrally and run median to VM axons and project to CC through NCC I and II similar to DH-IR in larva (Fig. 6F). This allowed unequivocal assignment of eNSF-IR cells to Type IIa4 cells. These data rule out most of the known hormones and peptides as candidates for colocalization with eNSR-IR, and thus it constitutes a novel reactivity.
Discussion
Mammalian cell-free systems and genetic studies in yeast have identified a large set of proteins that mediate intracellular transport. Subcellular localization and sequence conservation combined with genetic data have been used increasingly to implicate specific factors in distinct transport steps. Despite the overall conservation of mechanistic aspects between neurotransmitter release and endocrine secretion, far less about hormonal secretion in invertebrates is understood at the molecular level. Our interests are vested in understanding the molecular bases of hormonal secretion in the developmental model M. sexta. Here we have taken combined expression and complementation analyses to assign an in vivo role for M. sexta NSF. Our results clearly indicate that MsNSF is functional in yeast in vivo, and its expression levels are critical for this functional complementation. It is also clear that MsNSF is involved in intracellular trafficking in yeast and possibly in M. sexta. This is the first demonstration that an animal NSF could genetically complement the SEC18 mutation in yeast.
In vivo complementation by MsNSF in yeast occurs without its cofactor SNAP(s) from a homologous source. The higher expression levels required for functional complementation may be due to differences in properties of MsNSF such as its ATPase activity, affinity for Sec17p, or requirement for SNAP (-like) cofactors from an identical source and recognition of SNARE complexes in their right context and from the correct species. Vertebrate p97 (yeast Cdc48p) which, like NSF, has been implicated in fragment assembly of mitotic Golgi(Rabouille et al., 1995) is not functional in a yeast Cdc48p assay for ER membrane fusion; however, crude lysate from Xenopus possesses greater Cdc48p activity in vitro (Latterich et al.,1995). A reason for lack of complementation by vertebrate NSF and p97 in yeast SEC18 and CDC48 mutants might be that these proteins require their respective cofactors α-SNAP and p47 to be active in heterologous environments.
Each subunit of NSF hexamer can be divided into distinct domains (for a review, see May et al., 2001). The D1 domain provides the major ATPase activity in disassembling SNARE complexes (Matveeva et al.,1997; Nagiec et al.,1995; Steel and Morgan,1998). ATP binding to D2 is required for hexamerization of NSF but not for SNARE disassembly (May et al.,2001). The temperature-sensitive mutation of SEC18(89G → D) occurs in the N-domain implicated in interacting with SNAREs (A. Morgan; cited by May et al., 1999). Sequence divergence of this region among cloned NSFs might reflect its structural requirement for interacting with species-specific SNAP-SNAREs. By this criterion, one would expect MsNSF to have lower affinity for yeast SNAREs than Sec18p. Since the N-domain contains a critical pocket proposed to interact with SNAP and, in turn, with SNARE complex, subtle structural differences in this region would underlie the ability to discriminate the substrate from the right species. Another possibility is that MsNSF might be interacting with the mutant form of Sec18p in vivo to form a less functional heterooligomer, rather than all subunits being contributed by MsNSF to form a fully functional homo-hexamer. In vitro experiments suggest that this is an unlikely situation since NSF oligomer containing even a single mutant subunit is completely defective in fusion reactions (Whiteheart et al.,1994).
NSF assembles into a 20 S complex containing SNAREs and SNAP(Wilson et al., 1992). The 20 S complex contains three copies of SNAP bound to one hexameric NSF(Wimmer et al., 2001). Neuronal (Hayashi et al.,1995; Söllner et al.,1993a) and yeast (Rossi et al., 1997) SNAREs also bind three SNAP and Sec17p, respectively,indicating a conserved behaviour in SNARE:SNAP:NSF complex formation. Even though NSF ATPase activity is essential for breaking apart the SNARE complex,the comatose equivalent of CHO NSF (274G→E),deficient in ATPase activity, could nonetheless mediate membrane fusion(Müller et al., 1999). These data imply that NSF possibly functions in steps other than the well-studied ATPase-dependent SNARE disassembly-mediated reactions(Schwarz, 1999).
The precise function of NSF in membrane fusion is controversial. NSF-mediated SNARE disassembly might precede fusion(Banerjee et al., 1996) or in a priming step after docking (Kawasaki et al., 1998), or after fusion to initiate another cycle of fusion(Littleton et al., 1998, 2001; Schweizer et al., 1998). Mutations in Drosophila NSF1 result in the accumulation of docked vesicles (Kawasaki et al.,1998). This may result from undissociated SNARE complex on vesicles that are recycled, or on the plasma membrane formed after fusion in comatose flies. Such tangled SNAREs would be incapable of forming productive v-t-SNAREs in trans. NSF-mediated disassembly in wild-type synapses would relieve this constraint after fusion, such that v-SNARE from SNARE bundles formed after fusion are recycled efficiently on endocytosed vesicles, leaving t-SNAREs on plasma membrane free to pair with incoming v-SNARE. Since these events can be viewed as `beginning' and `end' reactions within one round of fusion, prevailing data support the action of NSF not during fusion but in disentangling SNARE bundles residing on the same membrane(cis-SNAREs), formed after fusion (Littleton et al., 1998, 2001; Tolar and Pallanck, 1998). This interpretation is also consistent with Sec18p in yeast vacuolar fusion,where it mediates an ATP-dependent priming of vacuoles even before fusion partners come in contact with each other(Ungermann et al., 1998; Wickner and Haas, 2000).
Structural studies on NSF (Lenzen et al., 1998; May et al.,1999; Yu et al., 1998, 1999), Sec18p(Babor and Fass, 1999) and p97(Rouiller et al., 2000; Zhang et al., 2000) are providing new avenues for improving our understanding of how conformational changes associated with nucleotide binding and hydrolysis might possibly disassemble SNAREs (see Dalal and Hanson,2001; Hanson et al.,1997; May et al.,2001). Similar to neuronal activity-dependent phosphorylation of synaptic proteins (Greengard et al.,1993), vertebrate NSF could be phosphorylated by protein kinase C(PKC) in synaptosomes (Matveeva et al.,2001), which is consistent with our previous proposal(Pullikuth and Gill, 1999). It remains to be seen how such modifications can modulate the several membrane fusion reactions that are catalyzed by NSF.
NSF is critical for synaptic transmission, since vesicles accumulate(Kawasaki et al., 1998) and lead to paralysis when its function is impaired(Pallanck et al., 1995a; Siddiqi and Benzer, 1976). Apart from its better-understood role in neurotransmitter release, NSF mediates trafficking or proper insertion of glutamate receptor subunits at postsynaptic sites (Osten et al.,1998; Song et al.,1998). Further, NSF interacts with β2-adrenergic receptor (Cong et al., 2001)and β-arrestin 1 (McDonald et al.,1999), probably to facilitate receptor internalization and recycling. This indicates that NSF might have varied functions depending on the local cellular context. Despite its established role in neurotransmission,little is known about NSF distribution and function in insect endocrine cells. Our histochemical analysis of MsNSF expression suggests that, in M. sexta, NSF expression is under developmental control. The specific enrichment of MsNSF in Type IIa4 cells suggests that NSF plays a physiologically important role in later development. We did not detect significant colocalization of neuropeptides and hormones with MsNSF enrichment. Thus, MsNSF expression in Type IIa4 cells is a novel phenotype. It has been speculated that TypeIIa4 cells, which produce diuretic hormone (DH) in larvae, are atrophied during pupal development since DH production shifts to a cluster of smaller cells derived from a common neuroblast (Veenstra and Hagedorn, 1991). Incidentally, DH immunoreactivity was the only means of readily identifying these cells. Our observation that NSF-IR localizes to Type IIa4 cells in late pupal and adult stages suggests that these cells are not atrophied but in fact might govern crucial behavior in development, probably through an NSF-dependent mechanism that regulates secretion from CC.
Another important aspect of NSF expression is at the level of sites known to release hormones and neuropeptides that are synthesized in the brain. If NSF were a constitutive member of the release machinery then one would expect its expression to be more or less uniform in all identified sites of hormone release. The fact that eNSF-IR is found only in CC and not in CA strongly indicates that its preferential role is mediating the release of a subset of hormones that are synthesized in the brain and released from CC. Hormones secreted from CA might thus use machinery distinct from NSF that is characterized here, or might be NSF-independent. Of the sequenced genomes, Drosophila is the only organism so far to have two distinct NSF homologues, dNSF1 and 2. dNSF1 is required for early adult development whereas dNSF2 is required for early larval development. The expression patterns of neither of them have been adequately examined in endocrine cells, even though one can genetically rescue the defect in the other(Golby et al., 2001). The D1 domain, towards which our antibody was raised, is highly conserved (>80%)in both dNSF homologues and would be expected to react with such homologues if present in M. sexta. MsNSF expression in a subset of enteric endocrine cells indicates that MsNSF might play a role in the regulation of processes emanating from factors produced in the midgut. The strategically located pediculate cells reactive for MsNSF are exposed to the hemolymph and thus could receive information from hemolymph-borne factors governing several aspects of development and homeostasis.
In summary, we have provided in vivo evidence for the functional role of MsNSF. Our results experimentally verify that MsNSF could functionally replace Sec18p in vivo. This supports the findings of Steel et al.(1999), who showed that purified Sec18p could participate in Ca2+-triggered exocytosis in chromaffin cells. The developmental regulation of NSF expression in neurosecretory cells points to a novel role of NSF in peptidergic pathways dictating developmental aspects of M. sexta. Enrichment of MsNSF in enteric endocrine cells suggests that NSF might play a preferential role in hormonal secretion in a subset of cells, whereas the remainder might use either NSF-independent pathways or other NSF-like molecules distinct from the one characterized here. We hope that this study will encourage the use of yeast as a tractable genetic system to understand key roles for proteins in secretion from organisms where cell-free assays are not currently available or are difficult to develop.
Acknowledgements
A.K.P. was funded in part through a Rotary International Fellowship. This project received support from NIH (AI 32572 and 48049) to S.S.G. We thank Drs E. C. Gaynor, S. D. Emr, R. W. Schekman, H. Reizman, T. H. Stevens, T. Graham,M. Makarow, M. G. Waters, V. Lupashin, W. Wickner, H. Bellens, D. Zitnan, M. E. Adams, T. Kingan, I. Sauman, A. Gotter, S. Reppert, W. Bollenbacher, D. Willows and J. Veenstra for sharing reagents with us. Special thanks to Candy Burkenbine for help with immunohistochemistry, E. C. Gaynor for helpful suggestions on immunoprecipitation, Chi-Sung Chiu for serum collection and D. Zitnan, J. Veenstra, T. Kingan and N. Davis for sharing their knowledge on insect hormones. We also thank the anonymous reviewers for suggesting improvements to the manuscript.